Qualified decisions based on credible data are necessary
Authors:
J. Holčík
Authors‘ workplace:
Ústav sociálního lékařství a veřejného zdravotnictví Lékařské fakulty MU Brno, přednosta prof. MUDr. Jan Holčík, DrSc.
Published in:
Vnitř Lék 2007; 53(6): 750-759
Category:
Forum
Adam Z et al. Pohled lékaře na změny v léčebných postupech vybraných krevních chorob a na náklady na tuto léčbu přináší otázky pro ekonomy a další odborníky. Vnitř Lék 2007; 53(6): 735–749.
Overview
This paper is a reaction to an article giving evidence on the growth in the cost of treatment of selected malignant blood diseases. The relationship between the market and health care is explained, as well as the principles of public and private health insurance. Principal decision-making factors such as scientifically proven data, personal or group values and preferences and political and logistic potential are referred to. Private health insurance in Great Britain is used to exemplify the strong and weak points of private health insurance in general. The author brings attention to the need for systematic negotiation with health insurance companies in making use of available data related both to the scope of the issue and potential solutions to it. In addition the author points out the importance of quality health services and efficient organisation of oncological health care. In the long run, the most important factor, from the author’s point of view, is systematic exploitation of the Health 21 programme, which is integral to the European health care policy.
Key words:
the market and health care – health insurance – quality health care services – Health 21 programme
Sources
1. Maynard A. Prioritising Health Care - Dreams and Reality. In: Malek M (ed). Setting Priorities in Health Care. New York: Wiley 1994.
2. Blayney KT. The Caduceus vs Staff of Asclepius, http://drblayney.com/Asclepius.html (5. 3. 2007).
3. Poupa O. Claude Bernard. Praha: Orbis 1967.
4. World Health Organisation: Health 21 - health for all in the 21st century. The health for all policy framework for the WHO European Region. European Health for All. Series No. 6. Copenhagen: WHO Regional Office for Europe 1999.
5. Donabedian A. Aspects of Medical Care Administration. Specifying requirements for Health Care. Cambridge: Harvard University Press 1973.
6. Pelc H. Sociální lékařství. Praha: Melantrich 1937.
7. Mossialos E, Le Grand J. Health Care and Cost Containment in the European Union. Cornwall: Ashgate Publishing Company 1999.
8. Foubister T et al. Private Medical Insurance in the United Kingdom. Copenhagen: European Observatory on Health Systems and Policies 2006.
9. Mossialos E, Thomson S. Voluntary Health Insurance in the European Union. Copenhagen: European Observatory on Health Systems and Policies 2004.
10. World Health Organisation. Quality of Care. A process for making strategic choices in health systems. Geneva: WHO 2006.
11. World Health Organisation: The World Health Report 2000. Health Systems: Improving Performance. Geneva: WHO 2000.
Labels
Diabetology Endocrinology Internal medicineArticle was published in
Internal Medicine
2007 Issue 6
Most read in this issue
- Cost of medication in the Czech Republic – causes of growth in costs and solution proposals
- Hypogonadism, a serious complication of chronic renal insufficiency
- Malignant arrhythmia in a patient with variant (Prinzmetal’s) angina pectoris
- Genetic factors and the risk of cardiovascular diseases